Yousif Capital Management LLC Takes $200,000 Position in Phibro Animal Health Corporation $PAHC

Key Points

• Yousif Capital Management LLC has acquired a new position in Phibro Animal Health Corporation, valued at approximately $200,000, by acquiring 7,837 shares during the second quarter.
• Phibro Animal Health reported earnings of $0.57 per share for its last quarter, surpassing the estimated $0.52, alongside a revenue of $378.70 million.
• The company recently announced a quarterly dividend of $0.12 per share, reflecting an annualized yield of 1.1%.

Yousif Capital Management LLC acquired a new position in shares of Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 7,837 shares of the company's stock, valued at approximately $200,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Phibro Animal Health by 4.7% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,164 shares of the company's stock worth $260,000 after purchasing an additional 546 shares in the last quarter. State of Alaska Department of Revenue grew its holdings in shares of Phibro Animal Health by 7.6% during the second quarter. State of Alaska Department of Revenue now owns 12,129 shares of the company's stock worth $309,000 after purchasing an additional 859 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its stake in shares of Phibro Animal Health by 10.0% in the second quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 11,530 shares of the company's stock valued at $294,000 after buying an additional 1,044 shares during the period. Financial Management Professionals Inc. bought a new position in Phibro Animal Health in the 2nd quarter valued at approximately $32,000. Finally, Algert Global LLC boosted its position in Phibro Animal Health by 1.4% during the 1st quarter. Algert Global LLC now owns 97,612 shares of the company's stock worth $2,085,000 after buying an additional 1,340 shares during the period. Institutional investors own 99.34% of the company's stock.

Phibro Animal Health Trading Up 3.1%

NASDAQ PAHC opened at $42.33 on Friday. The stock has a market capitalization of $1.72 billion, a P/E ratio of 35.87, a P/E/G ratio of 1.24 and a beta of 0.83. The business has a 50 day simple moving average of $37.88 and a 200 day simple moving average of $29.06. The company has a debt-to-equity ratio of 2.46, a current ratio of 2.76 and a quick ratio of 1.25. Phibro Animal Health Corporation has a one year low of $16.16 and a one year high of $42.80.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its quarterly earnings results on Wednesday, August 27th. The company reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.05. The firm had revenue of $378.70 million for the quarter, compared to analyst estimates of $362.24 million. Phibro Animal Health had a return on equity of 32.14% and a net margin of 3.73%. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. Research analysts expect that Phibro Animal Health Corporation will post 1.95 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 24th. Investors of record on Wednesday, September 3rd were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, September 3rd. This represents a $0.48 annualized dividend and a yield of 1.1%. Phibro Animal Health's dividend payout ratio is currently 40.68%.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on PAHC. JPMorgan Chase & Co. upgraded shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and upped their price target for the company from $25.00 to $35.00 in a research report on Monday, July 7th. Weiss Ratings reissued a "hold (c)" rating on shares of Phibro Animal Health in a research note on Tuesday, October 14th. Morgan Stanley set a $34.00 target price on Phibro Animal Health in a research report on Thursday, August 28th. Zacks Research raised Phibro Animal Health from a "hold" rating to a "strong-buy" rating in a report on Monday, September 29th. Finally, Bank of America upped their price target on Phibro Animal Health from $19.00 to $27.00 and gave the company an "underperform" rating in a research report on Friday, August 29th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, four have issued a Hold rating and two have given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $28.40.

Insider Buying and Selling

In other Phibro Animal Health news, CEO Jack Bendheim sold 3,520 shares of Phibro Animal Health stock in a transaction on Thursday, October 23rd. The shares were sold at an average price of $40.18, for a total value of $141,433.60. Following the completion of the sale, the chief executive officer directly owned 58,520 shares of the company's stock, valued at approximately $2,351,333.60. The trade was a 5.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders have sold 56,776 shares of company stock valued at $2,292,018 in the last ninety days. Company insiders own 50.13% of the company's stock.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.